Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1968 1
1975 1
1976 2
1977 5
1978 6
1979 3
1980 5
1981 8
1982 5
1983 5
1984 6
1985 4
1986 3
1987 3
1988 7
1989 32
1990 179
1991 438
1992 627
1993 721
1994 846
1995 1098
1996 1045
1997 1157
1998 1204
1999 1357
2000 1386
2001 1388
2002 1537
2003 1788
2004 1936
2005 2175
2006 2275
2007 2300
2008 2305
2009 2497
2010 2642
2011 3053
2012 3264
2013 3541
2014 3726
2015 3671
2016 3618
2017 3524
2018 3353
2019 3169
2020 3045
2021 257
Text availability
Article attribute
Article type
Publication date

Search Results

59,810 results
Results by year
Filters applied: . Clear all
Page 1
Advances in the treatment of HIV/HCV coinfection in adults.
Schlabe S, Rockstroh JK. Schlabe S, et al. Expert Opin Pharmacother. 2018 Jan;19(1):49-64. doi: 10.1080/14656566.2017.1419185. Expert Opin Pharmacother. 2018. PMID: 29252031 Review.
INTRODUCTION: Direct-acting antivirals (DAA) have revolutionized the modern treatment of chronic hepatitis C (HCV). These highly efficacious, well-tolerated, all-oral HCV regimens allow cure of HCV in over 95% of HCV-monoinfected as well as HIV/HCV
INTRODUCTION: Direct-acting antivirals (DAA) have revolutionized the modern treatment of chronic hepatitis C (HCV). These highly effi …
Protease Inhibitors (HCV).
[No authors listed] [No authors listed] 2016 Mar 10. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012–. PMID: 31644194 Free Books & Documents. Review.
The hepatitis C virus (HCV) specific protease inhibitors are a class of agents that block the enzymatic activity of the HCV NS3 protease region that is necessary for protein processing required for viral replication. ...The HCV protease inhibitors are approve …
The hepatitis C virus (HCV) specific protease inhibitors are a class of agents that block the enzymatic activity of the HCV NS …
Profile of Roche's cobas HCV tests.
Kessler HH, Stelzl E. Kessler HH, et al. Expert Rev Mol Diagn. 2017 Apr;17(4):311-319. doi: 10.1080/14737159.2017.1293526. Epub 2017 Feb 22. Expert Rev Mol Diagn. 2017. PMID: 28277143 Review.
Furthermore, the HCV genotype should be assessed prior to treatment initiation. Recently, Roche developed the cobas HCV tests for use on the cobas 6800/8800 Systems and the cobas 4800 System and the cobas HCV genotyping (GT) test for use on the cobas 4800 Sys …
Furthermore, the HCV genotype should be assessed prior to treatment initiation. Recently, Roche developed the cobas HCV tests …
Consensus statement on the management of patients with HCV infection in Romania.
Consensus Statement on HCV Infection in Romania Working Group. Consensus Statement on HCV Infection in Romania Working Group. Germs. 2017 Mar 1;7(1):32-39. doi: 10.18683/germs.2017.1106. eCollection 2017 Mar. Germs. 2017. PMID: 28331840 Free PMC article. Review.
Which patients with HCV infection do we treat? When do we start treatment for HCV infection? What regimens do we use for treating HCV infection? How do we monitor patients with HCV infection during treatment? ...
Which patients with HCV infection do we treat? When do we start treatment for HCV infection? What regimens do we use for treat …
HCV-2a NS5A downregulates viral translation predominantly through domain I.
Kandangwa M, Liu Q. Kandangwa M, et al. Biochem Biophys Res Commun. 2020 Aug 13;529(1):77-84. doi: 10.1016/j.bbrc.2020.05.177. Epub 2020 Jun 5. Biochem Biophys Res Commun. 2020. PMID: 32560823
We found that HCV-2a NS5A downregulates RNA translation of both HCV-2a and -1b, whereas the effect of HCV-1b NS5A is limited to HCV-1b only. In addition, individual regions of 3'UTR are not required for HCV-2a NS5A to downregulate viral RNA tran …
We found that HCV-2a NS5A downregulates RNA translation of both HCV-2a and -1b, whereas the effect of HCV-1b NS5A is li …
Feasibility of anti-HCV reflex HCV Ag screening strategy in an HCV endemic community.
Chen WM, Lee CY, Hsu NT, Huang WC, Chen MY, Huang TJ, Lu SN. Chen WM, et al. J Formos Med Assoc. 2020 Sep 29:S0929-6646(20)30454-X. doi: 10.1016/j.jfma.2020.09.013. Online ahead of print. J Formos Med Assoc. 2020. PMID: 33008696 Free article.
BACKGROUND/PURPOSE: The HCV core antigen (HCV Ag) assay displays high sensitivity and strong correlation with HCV RNA. ...CONCLUSION: Anti-HCV reflex HCV Ag screening is a feasible strategy for aiding HCV-prone communities....
BACKGROUND/PURPOSE: The HCV core antigen (HCV Ag) assay displays high sensitivity and strong correlation with HCV RNA. …
Threshold value of the anti-HCV test in the diagnosis of HCV infection.
Kirişci Ö, Calıskan A. Kirişci Ö, et al. J Infect Dev Ctries. 2019 Oct 31;13(10):914-919. doi: 10.3855/jidc.11657. J Infect Dev Ctries. 2019. PMID: 32084022 Free article.
INTRODUCTION: In the diagnosis of hepatitis C virus (HCV) infection, the first step is screening for anti-HCV antibodies, and positive results are generally confirmed with nucleic acid amplification tests. ...The aim of this study was to determine the most appropria …
INTRODUCTION: In the diagnosis of hepatitis C virus (HCV) infection, the first step is screening for anti-HCV antibodies, and …
Impact of interplay between autophagy and interferon-alpha in HCV and HCV/HIV infection.
Lajevardi B, Bamdad T, Choobin H, Jamalidoust M, Namayandeh M. Lajevardi B, et al. Acta Virol. 2019;63(2):235-239. doi: 10.4149/av_2019_214. Acta Virol. 2019. PMID: 31230454
The aim of this study was to compare the expression rate of the key gene for autophagy process, Beclin-1, as a cellular response to viral infections, and its effect on IFN-alpha expression in both HCV and HCV/HIV patient groups. In this study, a total number of 40 s …
The aim of this study was to compare the expression rate of the key gene for autophagy process, Beclin-1, as a cellular response to viral in …
HCV viraemia in anti-HCV-negative haemodialysis patients: Do we need HCV RNA detection test?
Papadopoulos N, Griveas I, Sveroni E, Argiana V, Kalliaropoulos A, Martinez-Gonzalez B, Deutsch M. Papadopoulos N, et al. Int J Artif Organs. 2018 Mar;41(3):168-170. doi: 10.1177/0391398817752326. Epub 2018 Feb 13. Int J Artif Organs. 2018. PMID: 29546809
However, previous studies have shown the presence of HCV viraemia in anti-HCV-negative haemodialysis patients as up to 22%. OBJECTIVES: To evaluate the presence of HCV viraemia, using HCV RNA detection, among anti-HCV-negative haemodialysis pati …
However, previous studies have shown the presence of HCV viraemia in anti-HCV-negative haemodialysis patients as up to 22%. OB …
Treatment of chronic HCV genotype 1 coinfection.
Boesecke C, Rockstroh JK. Boesecke C, et al. Curr HIV/AIDS Rep. 2015 Sep;12(3):326-35. doi: 10.1007/s11904-015-0278-4. Curr HIV/AIDS Rep. 2015. PMID: 26228050 Review.
Per both European and US treatment guidelines, HCV treatment indications and DAA drug selection in HIV-coinfected patients are no longer different from HCV-monoinfected patients as cure rates in HCV-monoinfected and HCV-coinfected patients are superimp …
Per both European and US treatment guidelines, HCV treatment indications and DAA drug selection in HIV-coinfected patients are no lon …
59,810 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page